US Stock MarketDetailed Quotes
SPRY ARS Pharmaceuticals
- 10.650
- +0.110+1.04%
Trading Jul 22 15:00 ET
1.03BMarket Cap-20480P/E (TTM)
10.770High10.485Low226.79KVolume10.620Open10.540Pre Close2.42MTurnover0.53%Turnover RatioLossP/E (Static)96.90MShares11.90052wk High4.61P/B459.32MFloat Cap2.55052wk Low--Dividend TTM43.13MShs Float63.410Historical High--Div YieldTTM2.70%Amplitude2.550Historical Low10.667Avg Price1Lot Size
ARS Pharmaceuticals Stock Forum
Sign in to post a comment
$ARS Pharmaceuticals(SPRY.US$ Ec Marketing Authorization Expected in Q3 2024
After Grant of Marketing Authorization by Ec Expected in Q3, Expects Eurneffy to Be Made Available to Patients in Europe in Q4
Eurneffy Same Data Package Under Review by FDA With a Pdufa Date of Oct 2
After Grant of Marketing Authorization by Ec Expected in Q3, Expects Eurneffy to Be Made Available to Patients in Europe in Q4
Eurneffy Same Data Package Under Review by FDA With a Pdufa Date of Oct 2
1
4
$ARS Pharmaceuticals(SPRY.US$ ARS Pharmaceuticals (SPRY) Price Target Increased by 56.25% to 12.75
2
$ARS Pharmaceuticals(SPRY.US$ new data will be presented at AAAAI meeting 23-26 Feb 2024
$Cellectar BioSciences(CLRB.US$ Phase 2
$Regenxbio(RGNX.US$ Phase 2
$Leap Therapeutics(LPTX.US$ Phase 2
$4D Molecular Therapeutics(FDMT.US$ Phase 2
$Adverum Biotechnologies(ADVM.US$ Phase 2
$Denali Therapeutics(DNLI.US$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US$ Phase 2
$Xencor(XNCR.US$ Phase 2
$Harmony Biosciences(HRMY.US$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US$ Phase 2
$Disc Medicine(IRON.US$ Phase 2
$Atea Pharmaceuticals(AVIR.US$ Phase 2
$Allakos(ALLK.US$ Phase 2 ...
$Regenxbio(RGNX.US$ Phase 2
$Leap Therapeutics(LPTX.US$ Phase 2
$4D Molecular Therapeutics(FDMT.US$ Phase 2
$Adverum Biotechnologies(ADVM.US$ Phase 2
$Denali Therapeutics(DNLI.US$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US$ Phase 2
$Xencor(XNCR.US$ Phase 2
$Harmony Biosciences(HRMY.US$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US$ Phase 2
$Disc Medicine(IRON.US$ Phase 2
$Atea Pharmaceuticals(AVIR.US$ Phase 2
$Allakos(ALLK.US$ Phase 2 ...
37
6
$ARS Pharmaceuticals(SPRY.US$ ARS Pharmaceuticals Announces Scheduling of a Type A Meeting With the U.S. FDA for Neffy (Epinephrine Nasal Spray)! PR makes this a close watch! Worth a complete read!![]()
$ARS Pharmaceuticals (SPRY.US)$ what can one say about this? so corrupt the FDA as it is. let's see how europe plays out by the end of this year, and that looks crucial to the co. in the near future. but one can be pretty sure that some big guys are now approaching the co. for a buyout deal. question is: what's the offer?
1
$ARS Pharmaceuticals(SPRY.US$ ARS Pharmaceuticals Likely to Get Approval for Epinephrine Nasal Spray in H2 2024, Wedbush Says! Check news tab for complete article![]()
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Monster madness : Guessing if they can get US approval also in the fall this will be a high double digit stock.
TrytosaveabitOP Monster madness: Howdy! So depending on where it’s trading at if/when that approval come? It very well could break up passed 13+! On another note. Yes this had some decent news for today. It just didn’t get much of a PI. The overall market was in pretty bad shape though. But it did get enough of a PI to finish making a nice small double bottom on the daily. So I will be watching very closely on Monday! See if the double bottom now continues and breaks upward! BTW sorry for the late reply! But Fridays I can’t be here after about 9:30AM est! I have a previous obligation that takes me away! I try to check in through the day if time permits. Like now. I had a few minutes before I jump in the truck to head home and decided to use the few free minutes to check in! Hope you had a good day.
Monster madness : Have a great weekend, your insight is always very appreciated
TrytosaveabitOP Monster madness: Thank you! You have a great weekend as well!